T. Kornishina

Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one

J. Stinson, J. Jaremko, A. Goris, 2017, Pediatric Rheumatology.

[Syndrome of autonomic dysfunction in children and adolescents].

T. I. Anisimova, L. Chutko, E. A. Yakovenko, 2018, Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova.

Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.

O. Kalashnikova, V. Chasnyk, E. Kuchinskaya, 2015, Seminars in arthritis and rheumatism.

FRI0551 Successful Treatment with TOCILIZUMAB Every 4 Weeks Distinguishes Low Disease Activity Group and Possibility to Achieve Drug-Free Remission in Patients with Systemic-Onset Juvenile Idiopathic Arthritis

O. Kalashnikova, V. Chasnyk, E. Kuchinskaya, 2014 .

Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study

V. Chasnyk, E. Suspitsin, M. Kostik, 2023, Biomedicines.

Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis

O. Kalashnikova, V. Chasnyk, E. Kuchinskaya, 2015, Pediatric Rheumatology.